DRKS00007716已完成不适用
Walter, S. (2017) Evaluation of a Palliative Care Training Program for Nurses - the ELNEC - Palliative Care Course Germany. Unpublished Masterthesis Albert-Ludwigs-Universität Freiburg
niversitätsklinikum Freiburg, Klinik für Palliativmedizin0 个研究点目标入组 18 人开始时间: 2015年1月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1) ELNEC-Trainer, who work in the akut care setting, home care or nursing and residential care homes
- •2) ELNEC-Trainer, who participate voluntary at narrative interviews
排除标准
- •ELNEC-Trainer, who refuse an interview
- •ELNEC-Trainer, whose senior refuse that the employee participate
研究者
相似试验
进行中（未招募）
1 期
An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patients with major depressive disorderEUCTR2007-003159-36-FRsanofi-aventis recherche & développement675
进行中（未招募）
不适用
An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patients with major depressive disorderEUCTR2007-003159-36-SEsanofi-aventis recherche & développement615
进行中（未招募）
不适用
An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patients with major depressive disorderEUCTR2007-003159-36-FIsanofi-aventis recherche & développement615
进行中（未招募）
不适用
An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study toEvaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as AdjunctiveTherapy in Adults With Major Depression Associated WithBipolar I DisorderMajor Depression Associated With Bipolar I DisorderMedDRA version: 9.1Level: LLTClassification code 10057840Term: Major depressionEUCTR2007-007555-14-HUCephalon, Inc.240
进行中（未招募）
不适用
An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study toEvaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as AdjunctiveTherapy in Adults With Major Depression Associated WithBipolar I DisorderMajor Depression Associated With Bipolar I DisorderMedDRA version: 9.1Level: LLTClassification code 10057840Term: Major depressionEUCTR2007-007555-14-BGCephalon, Inc.240